FDA finds no problem with heartburn drugs

Prilosec, Nexium don't cause heart risks, according to review

Health care videos

Appreciating options other than the public option
Dec. 9: The Interview: Rachel Maddow is joined by Rep. Anthony Weiner, D-NY, to talk about why he supports the new health reform compromise produced in the Senate even though he's an advocate for a public option.

Giving free health care to all

Progressives react to compromise

Facing the public option’s demise

Health bill compromise touted as breakthrough

INTERACTIVE

Dose of reality
Do health care reform headlines leave you saying “huh?” Visit msnbc.com's guide to health reform and send us claims you'd like fact-checked.

updated 11:47 a.m. ET Dec. 10, 2007

WASHINGTON - Patients who suffer from heartburn are not at increased risk for heart problems as a result of taking Prilosec or Nexium, according to a review released Monday by the Food and Drug Administration.

The FDA and its Canadian counterpart began reviewing the drugs, used by tens of millions of people, back in May. The drug's manufacturer, AstraZeneca, provided them with an early analysis of two small studies that suggested the possibility of a risk. The agency said its review of that study as well as 14 others indicated no increased risk for patients.

"FDA recommends that health care providers continue to prescribe, and patients continue to use these products as prescribed," the agency said.

Story continues below ↓

advertisement | your ad here

Nexium is the world's No. 2 selling drug, with 2006 sales of $6.7 billion, according to health care research firm IMS Health.

Don't miss this on msnbc.com Health

A year after pet food recall, still buyer beware
How one family walked off 191 pounds
Best walking cities in all 50 states
Junk-food dieters fake their way to skinny
Charges dropped for mom who left tot in car